检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:许春梅[1] 朱尚勇[2] 刘红燕[3] 陈彦红[1] 万里凯[4] 王小燕[1] 康利克[1]
机构地区:[1]广西壮族自治区人民医院超声科,南宁530021 [2]广西医科大学第一附属医院超声科,南宁530021 [3]广西壮族自治区人民医院内分泌科,南宁530021 [4]广西壮族自治区人民医院生殖医学与遗传中心,南宁530021
出 处:《中国临床新医学》2011年第9期816-819,共4页CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基 金:广西科技厅青年基金资助项目(编号:桂科青0339019)
摘 要:目的探讨抗甲状腺药物治疗两种彩超不同声像特征原发性甲亢的疗效。方法随机选择均匀回声型(均匀组)及不均匀回声型(不均匀组)原发性甲亢患者各31例,两组均用抗甲状腺药物治疗,于治疗前后检测甲状腺功能、甲状腺抗体,同时对甲状腺进行彩超检查,观察甲状腺声像、彩色血流分布,检测甲状腺大小及上动脉血流频谱参数。结果两组治疗前各检测指标差异无统计学意义(P>0.05),经抗甲状腺药物治疗后两组疗效比较差异有统计学意义(P<0.01)。均匀回声型治疗效果明显优于不均匀回声型(P<0.01),不均匀回声型组其危险度高于均匀回声型组(OR=12.923,P=0.000,95%CI:3.225~51.781)。结论抗甲状腺药物对原发性甲亢均匀回声型疗效较好,对不均匀回声型疗效较差,这对临床治疗方法的选择有重要的参考意义。Objective To investigate the curative effects of antithyroid drug (ATD) on the patients with primary hyperthyroidism (PHT) of different imaging. Methods Sixty-two patients with PHT of different imaging [ homogeneous echo ( n = 31 ) and inhomogeneous echo (n = 31 ) ] were randomly chosen and were treated with ATD. The volume of thyroid gland (V) was examined by using B-ultrasound and systolic and diastolic blood flow velocity (Vmax, Vmin) and resistance index (RI) were examined by using CDFI in these two groups. Serum levels of TT3, TT4, FT3, FT4, TSH, TRH, TRAb, TGAb and TMAb were also assayed before and after treatment. Results Therewas no significant difference in V, Vmax, Vmin, RI, or FT3, FT4, TSH, TRAb before treatment(P 〉0. 05), but significant difference after treatment in the curative effects between the two groups (P 〈 0. 05). The curative effects in homogeneous echo group was better than that in inhomogeneous echo group (P 〈 0. 05 ). Conclusion ATD treat- ment has good curative effects on the patients with PHT of homogeneous echo, but bad curative effects on those of inhomogeneous echo. It is very important in treatment.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117